ALVOTECH SA (ALVO) Stock Overview
NASDAQ:ALVO - LU2458332611 - Common Stock
ALVO Key Statistics, Chart & Performance
The current stock price of ALVO is 8.07 USD. In the past month the price decreased by -8.19%. In the past year, price decreased by -30.91%.
ALVO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.87 | 371.68B | ||
| AMGN | AMGEN INC | 13.19 | 154.89B | ||
| GILD | GILEAD SCIENCES INC | 14.6 | 140.17B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.08 | 100.25B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.72 | 61.55B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 58.53B | ||
| ARGX | ARGENX SE - ADR | 76.83 | 43.59B | ||
| ONC | BEONE MEDICINES LTD-ADR | 6.16 | 36.38B | ||
| INSM | INSMED INC | N/A | 28.77B | ||
| BNTX | BIONTECH SE-ADR | N/A | 24.04B | ||
| NTRA | NATERA INC | N/A | 23.09B | ||
| BIIB | BIOGEN INC | 8.26 | 19.38B |
Related stock screener links
About ALVO
Company Profile
Alvotech is a biotechnology company, which engages in the development and manufacture of biosimilar medicines. The firm is focused on the development and manufacture of biosimilar medicines for patients globally. The company is engaged in developing a pipeline of monoclonal antibodies that target a variety of therapeutic areas including inflammatory diseases, oncology, and ophthalmology. The Company’s pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Its products pipeline includes AVT02, AVT04, AVT23, AVT03, AVT05, AVT06, AVT16, and AVT33. Its AVT02 is a monoclonal antibody and a biosimilar to Humira (adalimumab). AVT04 is a monoclonal antibody and a biosimilar candidate to Stelara (ustekinumab). The company has formed a network of strategic commercial partnerships to provide global reach and leverage expertise in markets that include the United States (U.S.), Europe, Japan, China, and other Asian countries and large parts of South America, Africa, and the Middle East.
Company Info
ALVOTECH SA
9, Rue De Bitbourg
Luxembourg LU
Employees: 1012
Phone: 35244224500
ALVOTECH SA / ALVO FAQ
What is the stock price of ALVOTECH SA today?
The current stock price of ALVO is 8.07 USD. The price increased by 0.25% in the last trading session.
What is the ticker symbol for ALVOTECH SA stock?
The exchange symbol of ALVOTECH SA is ALVO and it is listed on the Nasdaq exchange.
On which exchange is ALVO stock listed?
ALVO stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for ALVOTECH SA stock?
10 analysts have analysed ALVO and the average price target is 17.85 USD. This implies a price increase of 121.19% is expected in the next year compared to the current price of 8.07. Check the ALVOTECH SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ALVOTECH SA worth?
ALVOTECH SA (ALVO) has a market capitalization of 2.51B USD. This makes ALVO a Mid Cap stock.
How many employees does ALVOTECH SA have?
ALVOTECH SA (ALVO) currently has 1012 employees.
What are the support and resistance levels for ALVOTECH SA (ALVO) stock?
ALVOTECH SA (ALVO) has a support level at 8.06 and a resistance level at 8.34. Check the full technical report for a detailed analysis of ALVO support and resistance levels.
Is ALVOTECH SA (ALVO) expected to grow?
The Revenue of ALVOTECH SA (ALVO) is expected to grow by 41.5% in the next year. Check the estimates tab for more information on the ALVO EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ALVOTECH SA (ALVO) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ALVO, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ALVO, evaluating the profitability, health, valuation and growth aspects
- ALVOTECH SA (ALVO) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ALVOTECH SA (ALVO) Sales and EPS estimates to see what analysts future expectations are.
- ALVOTECH SA (ALVO) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ALVOTECH SA (ALVO) Insider and Institutional Ownership to learn about the owners and their transactions.
- ALVOTECH SA (ALVO) Stock Chart to make your own analysis
- ALVOTECH SA (ALVO) Latest news and press-releases to stay up to date.
Does ALVOTECH SA (ALVO) stock pay dividends?
ALVO does not pay a dividend.
When does ALVOTECH SA (ALVO) report earnings?
ALVOTECH SA (ALVO) will report earnings on 2025-11-12, after the market close.
What is the Price/Earnings (PE) ratio of ALVOTECH SA (ALVO)?
ALVOTECH SA (ALVO) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.87).
What is the Short Interest ratio of ALVOTECH SA (ALVO) stock?
The outstanding short interest for ALVOTECH SA (ALVO) is 0.94% of its float. Check the ownership tab for more information on the ALVO short interest.
ALVO Technical Analysis
ALVO Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to ALVO. There are concerns on the financial health of ALVO while its profitability can be described as average.
ALVO Financial Highlights
Over the last trailing twelve months ALVO reported a non-GAAP Earnings per Share(EPS) of -0.87. The EPS increased by 64.39% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 16.42% | ||
| ROA | 7.75% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
ALVO Forecast & Estimates
10 analysts have analysed ALVO and the average price target is 17.85 USD. This implies a price increase of 121.19% is expected in the next year compared to the current price of 8.07.
For the next year, analysts expect an EPS growth of 96.48% and a revenue growth 41.5% for ALVO